刘新泳山东大学主页平台管理系统--中文主页

Combination treatment of Ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer: 点击次数：; 所属单位：药学院; 发表刊物：Drug Discovery Therapeutics; 全部作者：郭秀丽,刘新泳; 第一作者：郭秀丽; 论文类型：基础研究; 论文编号：lw-158888; 卷号：8; 期号：1; 页面范围：33; 是否译文：否; 发表时间：2014-03-01

上一条： Tetramethylpyrazine analogue CXC195 protects against cerebral ischemia/reperfusion-induced apoptosis through PI3K/Akt/GSK3β pathway in rats

下一条： DLJ14, a novel chemo-sensitization agent, enhances therapeutic effects of adriamycin against MCF-7/A cells both in vitro and in vivo